A trial comparing 2 combinations of chemotherapy for bowel cancer (FOXTROT 3)
This trial is comparing a combination of 2 chemotherapy drugs with a combination of 3 chemotherapy drugs for bowel cancer.
Cancers of the large bowel (colon)and back passage (rectum). Also called colorectal cancer or large bowel cancer.
This trial is comparing a combination of 2 chemotherapy drugs with a combination of 3 chemotherapy drugs for bowel cancer.
This trial is looking at chemotherapy before surgery for bowel cancer to improve treatment.
This trial is looking to see if having pembrolizumab before surgery improves treatment for bowel cancer that has a high risk of coming back.
This study is looking at using the SonoTran Platform in combination with chemotherapy and a targeted drug.
This study is looking at a drug called INCB106385 by itself or with another immunotherapy called retifanlimab (INCMGA00012) for some advanced solid cancers.
This study is looking at what it is like for people with a learning disability to get cancer screening.
This trial is looking at biomarkers to see if more people could benefit from cetuximab and panitumumab.
This study is looking at using neurotensin and IL-8 to screen for bowel cancer and bowel polyps.
This trial is looking at durvalumab with standard treatment to shrink cancer of the back passage (rectal cancer) before having surgery to remove it.
This trial is looking at a new drug called HMBD-001 for solid cancers that have spread into the surrounding tissue or to another part of the body.